<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>MicroRNAs (miRNAs) regulate <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> and invasion via direct interaction with target <z:chebi fb="5" ids="33699">messenger RNAs</z:chebi> (<z:chebi fb="2" ids="33699">mRNAs</z:chebi>) </plain></SENT>
<SENT sid="1" pm="."><plain>We defined miRNAs involved in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (metastamirs) using an established in vitro <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) model of minimally metastatic cells (SW480 line) from a <z:mp ids='MP_0009314'>colon adenocarcinoma</z:mp> <z:e sem="disease" ids="C1402294" disease_type="Disease or Syndrome" abbrv="">primary lesion</z:e> and highly metastatic cells (SW620 line) from a metastatic lymph node from the same patient 1 year later </plain></SENT>
<SENT sid="2" pm="."><plain>We used microarray analysis to identify miRNAs differentially expressed in SW480 and SW620 cells, focusing on miR-499-5p as a novel candidate prometastatic miRNA whose functions in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> had not been studied </plain></SENT>
<SENT sid="3" pm="."><plain>We confirmed increased miR-499-5p levels in highly invasive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines and lymph node-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> specimens </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, enhancing the expression of miR-499-5p promoted <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell migration and invasion in vitro and lung and <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> in vivo, while silencing its expression resulted in reduced migration and invasion </plain></SENT>
<SENT sid="5" pm="."><plain>Additionally, we identified FOXO4 and PDCD4 as direct and functional targets of miR-499-5p </plain></SENT>
<SENT sid="6" pm="."><plain>Collectively, these findings suggested that miR-499-5p promoted <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells and may be useful as a new potential therapeutic target for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>